We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+23.21%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$99.5M
AUM Growth
+$4.62M
(+4.9%)
Cap. Flow
-$4.26M
Cap. Flow
% of AUM
-4.28%
Top 10 Holdings %
Top 10 Hldgs %
44.59%
Holding
87
New
5
Increased
10
Reduced
44
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Inogen
INGN
|
+$996K |
| 2 |
NeuroOne Medical Technologies
NMTC
|
+$923K |
| 3 |
Ondas Inc
ONDS
|
+$831K |
| 4 |
Perion Network
PERI
|
+$700K |
| 5 |
MDxHealth
MDXH
|
+$447K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTLP
Cantaloupe
CTLP
|
+$1.85M |
| 2 |
Exagen
XGN
|
+$1.16M |
| 3 |
Village Farms International
VFF
|
+$798K |
| 4 |
Natera
NTRA
|
+$635K |
| 5 |
Fastenal
FAST
|
+$394K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 57.43% |
| 2 | Technology | 23.96% |
| 3 | Communication Services | 10.24% |
| 4 | Industrials | 4.64% |
| 5 | Consumer Staples | 2.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Rockwell Medical
RMTI
$28.5M
| $61K | 0.06% |
7,192
| – | – |
|
|
SCPH
77
DELISTED
scPharmaceuticals
SCPH
| $51.4K | 0.05% |
13,500
-3,700
| -22% | -$11.5K |
|
78
Alphatec Holdings
ATEC
$1.56B
| $49.5K | 0.05% |
179,817
-700
| -0.4% | -$8.04K |
|
79
Dyadic International
DYAI
$38.6M
| $47.4K | 0.05% |
47,850
| – | – |
|
80
IRIDEX
IRIX
$14.4M
| $41.7K | 0.04% |
47,300
| – | – |
|
81
Senseonics Holdings Inc
SENS
$272M
| $38.1K | 0.04% |
4,000
+700
| +21% | +$8.17K |
|
82
Pulmonx
LUNG
$89.5M
| $25.9K | 0.03% |
+10,000
| New | +$39.4K |
|
83
Airgain
AIRG
$72.1M
| $5.38K | 0.01% |
36,500
| – | – |
|
|
CTLP
84
DELISTED
Cantaloupe
CTLP
| – | – |
-234,600
| Closed | -$1.85M |
|
|
STRM
85
DELISTED
Streamline Health Solutions
STRM
| – | – |
-12,743
| Closed | -$35.7K |
|
|
86
Village Farms International
VFF
$236M
| – | – |
-1,318,500
| Closed | -$798K |
|
87
ExxonMobil
XOM
$643B
| – | – |
-1,694
| Closed | -$201K |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
FTEA
WT
BAM
Perkins Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Perkins Capital Management held 87 positions worth $99.5M, up 4.9% from $94.8M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Perkins Capital Management withdrew a net $4.26M in Q2 2025, closing 4 positions and reducing 44 holdings. Its most notable exit was Cantaloupe, an estimated $1.85M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 62% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Perkins Capital Management opened a new position in Inogen worth $1.04M.
- Perkins Capital Management's largest Q2 2025 buy was Inogen: 148,050 shares worth $1.04M.
- Perkins Capital Management added most to Perion Network in Q2 2025, an estimated $700K increase.
- Perkins Capital Management's biggest Q2 2025 reduction was Exagen, cutting an estimated $1.16M.
- Perkins Capital Management fully exited Cantaloupe in Q2 2025, selling an estimated $1.85M.
- Perkins Capital Management's ten largest holdings make up 45% of its $99.5M portfolio in Q2 2025.
- Perkins Capital Management opened 5 new positions and closed 4 in Q2 2025.
- Perkins Capital Management's portfolio value rose 4.9% quarter-over-quarter to $99.5M.
Based on Perkins Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.